Previous Page  26 / 36 Next Page
Information
Show Menu
Previous Page 26 / 36 Next Page
Page Background

CAMLOG&Science – Chapter 5

CLINICAL

STUDIES

A WELL DOCUMENTED IMPLANT SYSTEM

There is general agreement between clinicians that the scientific documen-

tation of an implant system reflects the engagement of a company in research

and science.When selecting themost appropriate treatment, long-termclinical

data represent a reference in terms of confidence not only for the user but

also for the patient. A large number of clinical studies have been performed

documenting the CAMLOG

®

Implant System with its Promote

®

surface in

several indications and loading modalities. Results have been published in

peer-reviewed journals or presented at congresses. Long-term results with

follow-up controls between four and a half years and seven years have been

documented in studies with more than 11,000 implants (Tab. 6). They have

confirmed excellent implant survival and success rates between 97.8 to

99.8%.

*Presentation at First International Camlog Congress in Montreux 2006

(1) CAMLOG, (2) Straumann, (3) Nobel, (4) Friadent, (5) Steri-Oss, (6) Brånemark, (7) others

Studies with observation periods from five years up to seven years with reported implant survival

or success rate. Data published in peer-reviewed journals or presented at congresses.

Tab. 6:

Selected publicated and presented clinical studies

Authors

Country

FU (up to

Total

CAMLOG

Survival or

years)

Impl.

Impl.

Success

in%

Krennmair et al., 2008a

AUT

7

183

1,4

174

97.80

Semper et al., 2008

GER

6

464

1

464

99.60

Franchini et al., 2011

IT

6

201

1

201

99.50

Krennmair et al., 2010

AUT

5

541

1

541

97.30

Zafiropoulos et al., 2010

GER

5

252

1,2

118

95.20

Nelson et al., 2008

GER

5

232

1,2

463

99.40

Semper et al., 2007

GER

5

448

1,2

403

99.80

Wolf 2007

GER

5

245

1,3

151

98.40

Özkan et al., 2011

TR

5

244

1,2,4

90

99.59

Xiang et al. 2010, 2011

GER

5

353

1

234

Max. 98.72

119

Mand. 99.15

Referent presentation*

Ackermann / Kirsch

AUT

7

3.588

1

3.588

98.60

Babbush

USA

7

273

1

273

98.90

Singer

GER

5

364

1

364

99.26

Watanabe

JP

5

552

1

552

98.60

Lin

PRCH

4.5

3.374

1

3.374

99.30

TOTAL CAMLOG IMPLANTS

11.109